(Q43614958)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sun Young Rha

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Hyun Cheol Chung

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Nam-Kyu Kim

1 reference

ORCID Public Data File 2021

author name string

K Y Shim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

H C Jeung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

N C Yoo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

N K Kim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J K Roh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J S Min

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

B S Kim

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

215-224

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

The role of adjuvant chemotherapy in the treatment of colorectal cancer

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

Current Status of Adjuvant Therapy in the Treatment of Large Bowel Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

Chemotherapy of Gastrointestinal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: summation dose-intensity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A Mayo Clinic/North Central Cancer Treatment Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900485-2

7 January 2021

10.1016/S0304-3835(01)00485-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369143%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference